Pilar Nicolás Jiménez
YOU?
Author Swipe
View article: Acceso a la secuencia genómica (II). Consideraciones éticas, legales y sociales
Acceso a la secuencia genómica (II). Consideraciones éticas, legales y sociales Open
La secuenciación genómica es ampliamente utilizada hoy en día en investigación y en la práctica clínica. Genera una ingente cantidad de datos crudos que, debidamente analizados e interpretados, se comunican a la persona secuenciada vincula…
View article: Cost-effectiveness analysis of artificial intelligence (AI) in earlier detection of liver lesions in cirrhotic patients at risk of hepatocellular carcinoma in Italy
Cost-effectiveness analysis of artificial intelligence (AI) in earlier detection of liver lesions in cirrhotic patients at risk of hepatocellular carcinoma in Italy Open
This study suggests that an AI-based approach to detect HCC earlier in cirrhotic patients can be cost-effective. By incorporating cost-effective AI-based approaches in clinical practice, patient outcomes and healthcare efficiency are impro…
View article: La función de los CEI en los proyectos de investigación multicéntricos. Propuestas para una intervención coordinada
La función de los CEI en los proyectos de investigación multicéntricos. Propuestas para una intervención coordinada Open
View article: Presentación (Núm.60 RDGH)
Presentación (Núm.60 RDGH) Open
Con gran satisfacción presentamos el sexagésimo número de la «Revista de Derecho y Genoma Humano. Genética, Biotecnología y Medicina Avanzada / Law and the Human Genome Review. Genetics, Biotechnology and Advanced Medicine». Este número, q…
View article: Regulación de los hallazgos secundarios e incidentales derivados del análisis genético: desde el ámbito clínico hasta el Espacio Europeo de Datos de Salud
Regulación de los hallazgos secundarios e incidentales derivados del análisis genético: desde el ámbito clínico hasta el Espacio Europeo de Datos de Salud Open
El desarrollo y disponibilidad de tecnologías ómicas de alto rendimiento, como la secuenciación completa del exoma (WES) y del genoma (WGS), suscitan nuevos retos ético-jurídicos. En este estudio normativo abordamos los retos relativos al …
View article: New implementation of data standards for AI in oncology: Experience from the EuCanImage project
New implementation of data standards for AI in oncology: Experience from the EuCanImage project Open
Background An unprecedented amount of personal health data, with the potential to revolutionize precision medicine, is generated at health care institutions worldwide. The exploitation of such data using artificial intelligence (AI) relies…
View article: New implementation of data standards for AI in oncology. Experience from the EuCanImage project
New implementation of data standards for AI in oncology. Experience from the EuCanImage project Open
Background An unprecedented amount of personal health data, with the potential to revolutionise precision medicine, is generated at healthcare institutions worldwide. The exploitation of such data using artificial intelligence relies on th…
View article: Reconciling the biomedical data commons and the GDPR: three lessons from the EUCAN ELSI collaboratory
Reconciling the biomedical data commons and the GDPR: three lessons from the EUCAN ELSI collaboratory Open
View article: Bridging the European Data Sharing Divide in Genomic Science
Bridging the European Data Sharing Divide in Genomic Science Open
In this viewpoint, we argue for the importance of creating data spaces for genomic research that are detached from contexts in which fundamental rights concerns related to surveillance measures override a purpose-specific balancing of fund…
View article: [Half a century of newborn screening in Spain: Evolution of ethical, legal and social issues (ELSIs). Part III, social issues.]
[Half a century of newborn screening in Spain: Evolution of ethical, legal and social issues (ELSIs). Part III, social issues.] Open
Decision making for the development of newborn screening programs is based on not only medical but also social concerns and involves different stakeholders. Part III of the article focuses on their role in the governance of the programs. F…
View article: TOMA DE DECISIONES AL FINAL DE LA VIDA
TOMA DE DECISIONES AL FINAL DE LA VIDA Open
This paper analyzes, from a strictly legal perspective, the different legislative initiatives presented in the Spanish Congress of Deputies during the present legislature aimed at the regulation of End-of-life decision making. To this end,…
View article: TOMA DE DECISIONES AL FINAL DE LA VIDA
TOMA DE DECISIONES AL FINAL DE LA VIDA Open
El presente trabajo pretende abordar, desde una perspectiva eminentemente jurídica, una serie de iniciativas legislativas presentadas en el Congreso de los Diputados durante la presente legislatura orientadas a la regulación de la toma de …
View article: Biobank External Ethics Committees (BEEC) in Spain. Nature, functions and operating procedures
Biobank External Ethics Committees (BEEC) in Spain. Nature, functions and operating procedures Open
Law 14/2007, of July 3, on Biomedical Research established the legal regimen for the use of human biological samples for biomedical research purposes. This regimen was subsequently implemented by Royal Decree 1716/2011, of November 18, whi…
View article: The EU General Data Protection Regulation: How will it impact the regulation of research biobanks? Setting the legal frame in the Mediterranean and Eastern European area
The EU General Data Protection Regulation: How will it impact the regulation of research biobanks? Setting the legal frame in the Mediterranean and Eastern European area Open
On 25 May 2018, the EU General Data Protection Regulation (GDPR) will come into force. As with the Data Protection Directive (95/46/EC), the regulation of biobanks for scientific research will be profoundly affected by this reform. Accordi…
View article: Non-coding recurrent mutations in chronic lymphocytic leukaemia
Non-coding recurrent mutations in chronic lymphocytic leukaemia Open